HUGE RESULTS. Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses
This chart is a sight to behold. Just WOW.
It's been a great week. I hope it continues...
next week would be fine.. thats where this nascent stock and industry are headed...california will lead the way
56k shares or 56k worth
$CYBN to Acquire Small Pharma Inc.
After phase 2, looking for the rare chance of a buyout. Although CEO wants to carry this all the way through, some pharma already contemplating greener pastures.
(Source: the Dale Report last interview) Just speculation yet, undervalued PPS, IAC...
Lincoln Park Capital Fund's past performance in the majority of companies that use this vulture fund show a sp decline of 38%. There are two ways to view this, though, as good or bad. Personally, I see this as an upcoming buying opportunity. Our ceo, Drysdale, seems a cut above the rest, IMO.
Cybin Announces US$30M Common Stock Purchase Agreement from Lincoln Park Capital Fund
$CYBN Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial!
Cybin Announces Last Subject Dosed in Part B of its Phase 1 CYB004-E Trial
We have a very impressive CEO:
Yesterday’s Panel discussion at Milken showed how far ahead we are in the quest to revolutionize the mental health care system.
Canaccord Genuity says $CYBN’s R&D event today will be pivotal for the company and it’s shareholders, $7 PT
Watch here: https://ir.cybin.com/investors/events-and-presentations/events/event-details/2023/Cybin-Virtual-RD-Day-2023-Innovating-New-Treatment-Approaches-for-Mental-Healthcare-2023-nICt-kZDwl/default.aspx
Yup taking a big position here tomorrow. Ripe!
Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004
- Marks first ever trial to evaluate deuterated DMT in humans –
- Based on preclinical studies CYB004 demonstrated superior bioavailability compared to IV DMT which may support less invasive dosing methods -
- CYB004 is a patented proprietary molecule protected through 2041 -
$CYBN: Nice day here...... now 0.49
She's rolling up here........... looks good